###begin article-title 0
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets
###end article-title 0
###begin title 1
Introduction
###end title 1
###begin p 2
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 331 337 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 374 384 366 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
Angiogenesis is an important process in the development of destructive synovial pannus in rheumatoid arthritis (RA). The ITGAV +gene encodes a cell cycle-associated antigen, integrin alphanubeta 3, which plays a role in RA angiogenesis. Previously, two independent studies identified an association between the major allele of the ITGAV single-nucleotide polymorphism (SNP) rs3738919 and RA. We therefore tested this association in an independent study using New Zealand (NZ) and Oxford (UK) RA case control samples.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919</italic>
###xml 306 316 306 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 340 350 340 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 678 687 678 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3911238</italic>
###xml 689 700 689 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10174098 </italic>
###xml 704 714 704 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
We compared genotype frequencies in 740 NZ Caucasian RA patients and 553 controls genotyped for rs3738919, using a polymerase chain reaction-restriction fragment length polymorphism assay. A TaqMan genotyping SNP assay was used to type 713 Caucasian RA patients and 515 control samples from Oxford for the rs3738919 variant. Association of rs3738919 with RA was tested in these two sample sets using the chi-square goodness-of-fit test. The Mantel-Haenszel test was used to perform a meta-analysis, combining the genetic results from four independent Caucasian case control cohorts, consisting of 3,527 cases and 4,126 controls. Haplotype analysis was also performed using SNPs rs3911238, rs10174098 and rs3738919 in the Wellcome Trust Case Control Consortium, NZ and Oxford case control samples.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 122 130 122 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic </italic>
###xml 122 130 122 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic </italic></sub>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 153 161 153 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic </italic>
###xml 153 161 153 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic </italic></sub>
###xml 345 355 345 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 396 405 396 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">combined </italic>
###xml 396 405 396 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>combined </italic></sub>
###xml 451 453 451 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
We found no evidence for association between ITGAV and RA in either the NZ or Oxford sample set (odds ratio [OR] = 0.88, Pallelic = 0.11 and OR = 1.18, Pallelic = 0.07, respectively). Inclusion of these data in a meta-analysis (random effects) of four independent cohorts (3,527 cases and 4,126 controls) weakens support for the hypothesis that rs3738919 plays a role in the development of RA (ORcombined = 0.92, 95% confidence interval 0.80 to 1.07; P = 0.29). No consistent haplotype associations were evident.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 25 35 25 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7378919 </italic>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
Association of ITGAV SNP rs7378919 with RA was not replicated in NZ or Oxford case control sample sets. Meta-analysis of these and previously published data lends limited support for a role for the ITGAV in RA in Caucasians of European ancestry.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Rheumatoid arthritis (RA) is a common systemic autoimmune disease characterised by chronic synovial inflammation leading to the formation of invasive, destructive pannus. The extensive formation of new blood vessels within the affected joint (hyperangiogenesis) is an important component of pannus formation [1].
###end p 10
###begin p 11
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 119 121 114 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s </sub>
###xml 171 172 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 196 205 191 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 336 342 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 350 351 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 352 353 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 390 395 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 398 399 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 446 447 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 448 449 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 504 509 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT4</italic>
###xml 512 513 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 580 587 575 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF/C5</italic>
###xml 590 591 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 592 594 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 595 597 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 626 628 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 629 631 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 426 431 <span type="species:ncbi:9606">human</span>
A heritable component to RA is supported by twin studies [2] and the markedly increased sibling recurrence risk (lambdas = 5 to 7.2) compared with the general population [3]. Association with the HLA-DRB1 locus is well established, with many other loci also incriminated. These include the protein tyrosine phosphatase non-receptor 22 (PTPN22) gene [4,5], cytotoxic T-lymphocyte antigen 4 (CTLA4) [6], an intergenic region on human chromosome 6 [7,8], signal transducer and activator of transcription 4 (STAT4) [9], the tumour necrosis factor receptor-associated factor 1 region (TRAF/C5) [7,10,11] and CD40, CCL21 and IL2RB [12,13].
###end p 11
###begin p 12
###xml 27 32 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV</italic>
###xml 375 376 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 377 379 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 380 382 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 517 519 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 697 699 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
The integrin alphanubeta3 (ITGAV) locus contains 30 exons spanning more than 90 kb of genomic DNA on human chromosome 2q31. It encodes the alphanu subunit of the cell cycle-associated antigen, integrin alphanubeta3, which plays a major role in RA angiogenesis. Angiogenesis is stimulated in RA by the increased metabolic demand of the pathologically active synovial tissues [1,14-16]. Potentially, inhibition of this angiogenesis might suppress the destructive activities of pannus and even control disease activity [17]. This is supported by studies in animal models in which injection of alphanubeta3 antagonists has shown inhibition of neovascularisation and attenuation of joint inflammation [18].
###end p 12
###begin p 13
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD51</italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 271 287 271 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV rs3738919 </italic>
###xml 376 383 376 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic</italic>
###xml 376 383 376 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic</italic></sub>
###xml 470 480 470 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 586 594 586 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic </italic>
###xml 586 594 586 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic </italic></sub>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 676 682 676 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 138 143 <span type="species:ncbi:9606">human</span>
A previous genome-wide linkage scan suggested 19 non-HLA regions contributing to RA in a French population [19]. One of these regions, on human chr2q31, contains the ITGAV gene (CD51). Subsequently, Jacq and colleagues [20] demonstrated an association between RA and the ITGAV rs3738919 C allele in a French Caucasian population (odds ratio for allele frequency difference [ORallelic] = 0.77, 95% confidence interval [CI] 0.63 to 0.94). Significant association with the rs3738919 C allele was also demonstrated from imputed data by the Wellcome Trust Case Control Consortium (WTCCC) (ORallelic = 0.91, 95% CI 0.83 to 1.00) [21]. Collectively, these studies suggest a role for ITGAV in RA and justify further investigation of this locus. We therefore tested this association in an independent study using New Zealand (NZ) and Oxford (UK) RA case control samples.
###end p 13
###begin title 14
Materials and methods
###end title 14
###begin title 15
Study subjects
###end title 15
###begin p 16
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 379 388 379 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 592 600 <span type="species:ncbi:9606">patients</span>
The NZ population-based Caucasian sample consists of 740 RA patients fulfilling the American College of Rheumatology (ACR) criteria for RA [22]. Of the patients for whom data were available, 34.3% (234/683) were male, 82.9% (538/649) were rheumatoid factor (RF)-positive, 68.1% (275/404) were anti-cyclic citrullinated peptide (anti-CCP)-positive and 79.4% (576/725) carried the HLA-DRB1 shared epitope. Ethical approval for recruitment of cases was given by the New Zealand Multi-Region Ethics Committee, and recruitment of the controls was approved by the Lower South Ethics Committee. All patients provided written informed consent for the collection of samples and subsequent analysis. The control sample consisted of 553 NZ European Caucasians (226/552 male; 40.9%) with no history of autoimmune disease.
###end p 16
###begin p 17
###xml 300 309 300 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
The 713 UK patients were recruited in Oxford, with informed consent from attendees at the rheumatology outpatient clinic at the Nuffield Orthopaedic Centre. All fulfilled the 1987 ACR criteria for RA; the average age of onset was 48 years, 28% were male, 77% were positive for RF and 77% carried the HLA-DRB1 shared epitope. Healthy ethnically matched controls (n = 515) were recruited from the same locale as that of blood donors. Approval for the study was given by the Oxford Research Ethics Committee (OxRec number C02.032).
###end p 17
###begin title 18
DNA extraction and genotyping
###end title 18
###begin p 19
###xml 193 199 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 236 246 236 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 534 544 534 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 592 595 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 705 715 705 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 822 833 822 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10174098 </italic>
###xml 837 853 837 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3911238 ITGAV </italic>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 157 169 <span type="species:ncbi:9606">participants</span>
###xml 673 685 <span type="species:ncbi:9606">participants</span>
DNA was extracted from peripheral blood samples of the RA patients and controls by means of guanidine isothiocyanate-chloroform extraction methods. NZ study participants were genotyped for the ITGAV single-nucleotide polymorphism (SNP) rs3738919 using a polymerase chain reaction-restriction fragment length polymorphic SNP genotyping assay as follows: forward primer CACTTTCTGTAAATTAGTGTTAGATCAAAAGG and reverse primer GCTTATAACTCACAATTCAGATTTTTGCC (primers from Sigma-Genosys, Sydney, Australia). The C allele (major allele) of the rs3738919 product (286 base pairs) was digested using the AluI restriction enzyme to form fragments of 223 and 63 base pairs. Oxford study participants were genotyped for rs3738919 using the TaqMan genotyping assay C___1278131_1, and both the NZ and Oxford samples were genotyped for the rs10174098 and rs3911238 ITGAV variants using the TaqMan genotyping assays C__30567648_10 and C___7617051_10, respectively, from Applied Biosystems (Scoresby, Australia).
###end p 19
###begin p 20
###xml 21 31 21 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 121 131 121 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
Although the imputed rs3738919 data were available and were previously reported by Ahnert and Kirsten [21], we reimputed rs3738919 genotypes in order to provide information on imputation parameters. RA case and control genotypes were imputed from the WTCCC dataset using IMPUTE software [23]. Genotypes were imputed from 89% of cases (n = 1,659) and 90% of controls (n = 2,639) using a 7-Mb region and a calling threshold of 0.7.
###end p 20
###begin title 21
Statistical analysis
###end title 21
###begin p 22
###xml 3 12 3 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a priori </italic>
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic </italic>
###xml 94 102 94 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic </italic></sub>
###xml 217 227 217 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 319 325 315 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 537 545 <span type="species:ncbi:9606">patients</span>
###xml 575 583 <span type="species:ncbi:9606">patients</span>
An a priori power calculation was made based on the combined French [20] and WTCCC [21] OR (ORallelic = 1.16), using 800 cases and 600 controls with a major allele frequency of 65%. The power to detect association of rs3738919 to RA using either the NZ or Oxford sample set was estimated to be 47%, using alpha = 0.05. ITGAV SNPs were tested for deviation from Hardy-Weinberg equilibrium in both the control and RA samples using a chi-square goodness-of-fit test. The significance of differences in the minor allele frequency between RA patients and controls, and stratified patients, was assessed using the chi-square goodness-of-fit test.
###end p 22
###begin p 23
###xml 12 18 12 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3911238</italic>
###xml 35 44 35 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2887827</italic>
###xml 46 56 46 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10174098</italic>
###xml 58 69 58 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs13006571 </italic>
###xml 73 83 73 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs16828163</italic>
###xml 112 121 112 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919</italic>
###xml 135 144 135 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3911238</italic>
###xml 146 157 146 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10174098 </italic>
###xml 161 170 161 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919</italic>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
Of the five ITGAV SNPs (rs3911238, rs2887827, rs10174098, rs13006571 and rs16828163) genotyped by the WTCCC and rs3738919, only three (rs3911238, rs10174098 and rs3738919) were required to tag all major haplotypes defined by the six variants. Haplotype association analysis was performed using the SHEsis software package [24], which uses a full-precise-iteration algorithm to construct haplotypes and estimate haplotype frequencies.
###end p 23
###begin p 24
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
Meta-analysis combining the French [20], WTCCC [25], NZ and Oxford samples was performed using STATA version 8.0 (StataCorp LP, College Station, TX, USA). The Mantel-Haenszel test was used to estimate the average conditional common OR between the four independent sample sets and to test for any heterogeneity between the four groups using both fixed and random effects. R software [26] was used to perform the Cochran-Armitage trend test to determine recessive, additive and dominant trend values (Table 1).
###end p 24
###begin p 25
###xml 36 45 36 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919</italic>
Allele and genotype distribution of rs3738919
###end p 25
###begin p 26
###xml 57 59 57 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
CI, confidence interval; HWE, Hardy-Weinberg equilibrium P value; OR, odds ratio; WTCCC, Wellcome Trust Case Control Consortium.
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
###xml 12 22 12 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
Analysis of rs3738919 in New Zealand and Oxford Caucasian rheumatoid arthritis samples
###end title 28
###begin p 29
###xml 13 23 13 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 136 144 136 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic </italic>
###xml 136 144 136 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic </italic></sub>
###xml 154 162 154 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic </italic>
###xml 154 162 154 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic </italic></sub>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 196 204 196 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic </italic>
###xml 196 204 196 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic </italic></sub>
###xml 214 222 214 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic </italic>
###xml 214 222 214 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic </italic></sub>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 594 601 <span type="species:ncbi:9606">patient</span>
We genotyped rs3738919 across the NZ and Oxford RA case control cohorts and found no evidence for an association between ITGAV and RA (Pallelic = 0.11; ORallelic = 0.88 [95% CI 0.75 to 1.03] and Pallelic = 0.07; ORallelic = 1.17 [95% CI 0.99 to 1.39], respectively) (Table 1). The direction of the NZ allele distribution is consistent with the previous French [20] and WTCCC [21] data, with the minor allele under-represented in the case groups in all three cohorts (Table 1). However, the allele distribution in the Oxford RA cohort differs in that the minor allele is over-represented in the patient group compared with the control group (Table 1).
###end p 29
###begin title 30
Haplotype analysis
###end title 30
###begin p 31
###xml 53 63 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 64 66 64 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 378 388 378 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 418 419 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 419 421 419 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 611 617 611 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 622 632 622 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3911238 </italic>
###xml 636 647 636 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10174098 </italic>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 702 712 702 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 719 720 719 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 916 918 916 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Association analysis using our imputed genotypes for rs3738919 (P = 0.04) from the WTCCC data were consistent with the previous report of an association of this SNP with RA in the WTCCC [21]. In our analysis, we obtained imputed genotypes from 89% of the WTCCC case control subjects. Presumably, this reflects the influence of the low linkage disequilibrium that exists between rs3738919 and the genotyped SNPs (0.01 <r2 < 0.54 in CEU [Centre d'Etude du Polymorphisme Humain Utah] HapMap [27]) on confidence calls of imputed genotypes. Haplotype analysis (Table 2) was performed using the actual genotypes from ITGAV SNPs rs3911238 and rs10174098 (Additional data file 1) and the imputed genotypes for rs3738919 (Table 1). One susceptibility haplotype (1-1-1), containing the major allele at each of the three SNPs, was significantly over-represented in cases compared with controls (OR = 1.15, 95% CI 1.02 to 1.30; P = 0.021).
###end p 31
###begin p 32
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 74 84 74 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10174098</italic>
###xml 86 95 86 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3911238</italic>
###xml 97 106 97 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919</italic>
Three-marker haplotype analysis of ITGAV single-nucleotide polymorphisms (rs10174098, rs3911238, rs3738919) in the Wellcome Trust Case Control Consortium, New Zealand and Oxford sample sets
###end p 32
###begin p 33
Only haplotypes with frequency of at least 0.05 in controls are shown. CI, confidence interval; HWE, Hardy-Weinberg equilibrium; OR, odds ratio; WTCCC, Wellcome Trust Case Control Consortium.
###end p 33
###begin p 34
###xml 9 19 9 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3911238 </italic>
###xml 23 34 23 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10174098 </italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 409 411 409 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Variants rs3911238 and rs10174098 were typed over the NZ and Oxford sample sets, and association of three-marker haplotypes was examined (Additional data file 1 and Table 2). There was no support for a positive association of the 1-1-1 haplotype with RA in either the NZ or Oxford sample set. There was a significant protective effect for this haplotype in the Oxford samples (OR = 0.78, 95% CI 0.62 to 0.99; P = 0.042).
###end p 34
###begin title 35
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
Meta-analysis of ITGAV in the four independent case control sample sets
###end title 35
###begin p 36
###xml 113 123 113 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 164 166 164 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1a</xref>
###xml 263 265 263 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 383 393 383 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 434 436 434 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1b</xref>
###xml 542 551 542 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919</italic>
###xml 573 580 <span type="species:ncbi:9606">patient</span>
Meta-analysis of all four sample sets, using a fixed effects model, revealed some evidence for an association of rs3738919 with RA (OR = 0.92, 95% CI 0.86 to 0.99; P = 0.021) (Figure 1a). Because of evidence for heterogeneity between the sample sets (Breslow-Day P = 0.011), a random effects model was also used for meta-analysis; this did not provide evidence for an association of rs3738919 with RA (OR = 0.92, 95% CI 0.80 to 1.07; P = 0.29) (Figure 1b). The Oxford sample set is significantly different from the other three sample sets at rs3738919; however, the Oxford patient sample set did not have any large differences in relation to gender (Oxford 28% male, NZ 34%, WTCCC 25%, France 13%), RF status (Oxford 77% positive, NZ 83%, WTCCC 84%, France 75%) or inheritance of the shared epitope (Oxford 77% positive, NZ 79%, WTCCC 79%, France 79%).
###end p 36
###begin p 37
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 58 68 58 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 243 247 243 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a) </bold>
###xml 268 272 268 272 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(b) </bold>
Meta-analysis of the ITGAV single-nucleotide polymorphism rs3738919 in four independent rheumatoid arthritis Caucasian cohorts: Jacq and colleagues [20], Wellcome Trust Case Control Consortium (WTCCC) [25], New Zealand and Oxford sample sets. (a) Fixed effects model. (b) Random effects model. CI, confidence interval.
###end p 37
###begin title 38
Stratification according to subphenotype
###end title 38
###begin p 39
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 180 190 180 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 259 269 259 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 336 338 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 455 457 455 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
The NZ and Oxford samples were stratified according to gender, RF and shared epitope status (Table 3). The stratification results did not reveal any significant differences in the rs3738919 genotype distribution for RA patients. There was a difference in the rs3738919 genotype distribution of male and female patients in the NZ cases (P = 0.026) (Table 3). However, a significant difference was not evident in either the Oxford or WTCCC case sample set (P = 0.55 and 0.80, respectively) (Table 3).
###end p 39
###begin p 40
###xml 25 35 25 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Subphenotype analysis of rs3738919 in rheumatoid arthritis patients
###end p 40
###begin p 41
RF, rheumatoid factor; SE, shared epitope; WTCCC, Wellcome Trust Case Control Consortium.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 58 68 58 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 168 170 168 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 535 545 535 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
###xml 565 567 565 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 634 643 634 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919</italic>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 967 976 963 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919</italic>
There was no evidence supporting a role for the ITGAV SNP rs3738919 in the etiology of RA when the NZ and the Oxford case control sample sets were analysed separately (P = 0.11 and 0.07, respectively) (Table 1). Trends for association were observed in both sets of samples, but in opposing directions (OR = 0.86 and 1.18, respectively). When all of the available sample sets were analysed together in a random effects model owing to the heterogeneity caused by the Oxford sample set, there was no longer evidence for an association of rs3738919 with RA (OR = 0.92; P = 0.29). To further investigate a potential association of RA with rs3738919, genotyping in a very large cohort will be required. The work previously undertaken by Thomson and colleagues [8] in confirming an association with RA of the Chr6q23 locus is an excellent example of how this can be achieved. A sample set of this size would have 69% power (alpha = 0.05; OR = 0.92) to detect association at rs3738919.
###end p 43
###begin p 44
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 479 493 479 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*0405 </italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 574 580 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*0401 </italic>
###xml 584 590 584 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*0404 </italic>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 759 765 759 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 851 856 851 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 891 892 891 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 983 988 983 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PADI4</italic>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1061 1062 1061 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1112 1122 1112 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FCRL3-169C</italic>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1168 1170 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1243 1245 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1335 1341 1335 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 1484 1490 1484 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 548 556 <span type="species:ncbi:9606">patients</span>
###xml 933 941 <span type="species:ncbi:9606">patients</span>
###xml 1013 1021 <span type="species:ncbi:9606">patients</span>
###xml 1155 1163 <span type="species:ncbi:9606">patients</span>
The rs3738919 ITGAV variant previously showed no association with RA in Japanese case-control samples [28]. These data were not included in our meta-analysis given that the major allele was present at a considerably different frequency in Japanese controls (0.92) than in Caucasian controls (France, 0.58; OXFORD, 0.64; and NZ, 0.63). It is already clear that there are genetic differences in susceptibility to RA between the Japanese and Caucasian populations. For example, the HLA-DRB1*0405 allele is most strongly associated with RA in Japanese patients [29] whereas the *0401 and *0404 alleles are more associated with RA in Caucasians [30]. Other genes showing population-specific effects in RA are the R620W variant of the protein tyrosine phosphatase, PTPN22, associated with Caucasian RA [4,5] but monomorphic in the Japanese population [31]; CTLA4, associated with RA in Caucasian [6] but not associated with RA in Japanese patients [32]; peptidylarginine deiminase type 4, PADI4, associated in Japanese patients [33,34] but very weakly in Caucasians [6,35,36]; and the Fc receptor-like 3 gene variant, FCRL3-169C, associated with RA in Japanese patients [37,38] and in one Caucasian study [39] but not in other Caucasian studies [40,41]. In conclusion, we have not been able to provide further support for the involvement of ITGAV in the etiology of RA in Caucasians. However, it is important that further genotyping be done in a large independent cohort to confirm whether ITGAV plays a role in RA.
###end p 44
###begin title 45
Conclusions
###end title 45
###begin p 46
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAV </italic>
###xml 125 135 125 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3738919 </italic>
In Caucasians, meta-analysis of 3,527 cases and 4,126 controls does not provide further evidence for a role of the ITGAV SNP rs3738919 in the development of RA.
###end p 46
###begin title 47
Abbreviations
###end title 47
###begin p 48
###xml 170 177 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">allelic</italic>
###xml 170 177 162 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>allelic</italic></sub>
ACR: American College of Rheumatology; CI: confidence interval; CTLA4: cytotoxic T-lymphocyte antigen 4; ITGAV: integrin alphanubeta3; NZ: New Zealand; OR: odds ratio; ORallelic: odds ratio for allele frequency difference; PTPN22: protein tyrosine phosphatase non-receptor 22; RA: rheumatoid arthritis; RF: rheumatoid factor; SNP: single-nucleotide polymorphism; WTCCC: Wellcome Trust Case Control Consortium.
###end p 48
###begin title 49
Competing interests
###end title 49
###begin p 50
The authors declare that they have no competing interests.
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
JEH-M and TRM helped to design the study, oversee its execution, and prepare the manuscript. KAR, AJP-G and MEM provided technical support. PG, AAH, PBBJ, LKS and PH helped to provide clinical recruitment and analyse data. ND, JH and BPW helped to provide clinical recruitment, analyse data, and prepare the manuscript. All authors read and approved the final manuscript.
###end p 52
###begin title 53
Supplementary Material
###end title 53
###begin title 54
Additional file 1
###end title 54
###begin p 55
###xml 36 47 36 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10174098 </italic>
###xml 51 60 51 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3911238</italic>
Allele and genotype distribution of rs10174098 and rs3911238. OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium; UK, United Kingdom; WTCCC, Wellcome Trust Case Control Consortium.
###end p 55
###begin p 56
Click here for file
###end p 56
###begin title 57
Acknowledgements
###end title 57
###begin p 58
###xml 20 26 <span type="species:ncbi:9606">people</span>
###xml 351 359 <span type="species:ncbi:9606">patients</span>
We thank all of the people who agreed to participate in our study and the Wellcome Trust Case Control Consortium for access to genotype data; Rachel Rodger, Helen Simkins, Wan Rohani Wan Taib and Cushla McKinney for assistance with laboratory work and data analysis; New Zealand research nurses Gael Hewett and Jill James for assistance in recruiting patients; and the Health Research Council of New Zealand and Arthritis New Zealand for their financial support of this work. This work was funded in part by a departmental grant from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
###end p 58
###begin article-title 59
Angiogenesis in rheumatoid arthritis
###end article-title 59
###begin article-title 60
Twin concordance rates for rheumatoid arthritis: results from a nationwide study
###end article-title 60
###begin article-title 61
Polygenic susceptibility in rheumatoid arthritis
###end article-title 61
###begin article-title 62
A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis
###end article-title 62
###begin article-title 63
Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort
###end article-title 63
###begin article-title 64
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4
###end article-title 64
###begin article-title 65
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study
###end article-title 65
###begin article-title 66
Rheumatoid arthritis association at 6q23
###end article-title 66
###begin article-title 67
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus
###end article-title 67
###begin article-title 68
Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility
###end article-title 68
###begin article-title 69
A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2
###end article-title 69
###begin article-title 70
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
###end article-title 70
###begin article-title 71
Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13
###end article-title 71
###begin article-title 72
Angiogenesis in pannus formation
###end article-title 72
###begin article-title 73
A role for angiogenesis in rheumatoid arthritis
###end article-title 73
###begin article-title 74
Recent data on the role for angiogenesis in rheumatoid arthritis
###end article-title 74
###begin article-title 75
Angiogenesis--a new target for future therapy
###end article-title 75
###begin article-title 76
###xml 48 55 <span type="species:ncbi:9986">rabbits</span>
Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist
###end article-title 76
###begin article-title 77
Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates
###end article-title 77
###begin article-title 78
The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study
###end article-title 78
###begin article-title 79
Association of ITGAV supports a role of angiogenesis in rheumatoid arthritis
###end article-title 79
###begin article-title 80
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
###end article-title 80
###begin article-title 81
A new multipoint method for genome-wide association studies by imputation of genotypes
###end article-title 81
###begin article-title 82
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
###end article-title 82
###begin article-title 83
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 83
###begin article-title 84
The R Project for Statistical Computing
###end article-title 84
###begin article-title 85
International HapMap Project
###end article-title 85
###begin article-title 86
ITGAV polymorphism and disease susceptibility in a Japanese rheumatoid arthritis population
###end article-title 86
###begin article-title 87
Positive and negative association of HLA-DR genotypes with Japanese rheumatoid arthritis
###end article-title 87
###begin article-title 88
###xml 79 82 <span type="species:ncbi:9606">men</span>
HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity
###end article-title 88
###begin article-title 89
Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population
###end article-title 89
###begin article-title 90
Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method
###end article-title 90
###begin article-title 91
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
###end article-title 91
###begin article-title 92
Association between PADI4 and rheumatoid arthritis: a replication study
###end article-title 92
###begin article-title 93
A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population
###end article-title 93
###begin article-title 94
A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population
###end article-title 94
###begin article-title 95
A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities
###end article-title 95
###begin article-title 96
Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis
###end article-title 96
###begin article-title 97
FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians
###end article-title 97
###begin article-title 98
Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity?
###end article-title 98
###begin article-title 99
Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association
###end article-title 99

